CBO Seeks Research On Obesity-Drug Cost Savings Potential

By Luke Zarzecki / October 5, 2023 at 4:30 PM

The Congressional Budget Office announced Thursday (Oct. 5) it will consider cost savings when it analyzes legislation involving anti-obesity medications if new research shows anti-obesity medications will save money for the broader health care system, and it suggested Congress consider tailoring its Medicare coverage legislation to those specific conditions for which new research shows savings.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.